• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498
• 3. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 4. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

6-Methyl-4-phenylquinazolin-2(1H)-one: A Comprehensive Overview

The compound with CAS No. 13961-64-3, commonly referred to as 6-Methyl-4-phenylquinazolin-2(1H)-one, is a significant molecule in the field of organic chemistry and pharmacology. This quinazolinone derivative has garnered considerable attention due to its unique structural properties and potential applications in drug discovery. The quinazolinone core of this compound is a well-known scaffold in medicinal chemistry, often associated with various bioactive properties. Recent studies have further elucidated its role in inhibiting key enzymes and pathways involved in diseases such as cancer, inflammation, and neurodegenerative disorders.

The synthesis of 6-Methyl-4-phenylquinazolin-2(1H)-one involves a series of well-established organic reactions, including condensation and cyclization processes. Researchers have optimized these methods to achieve high yields and purity, ensuring the compound's reliability for further studies. The methyl and phenyl substituents attached to the quinazolinone ring play a crucial role in modulating the molecule's physicochemical properties, such as solubility and lipophilicity, which are critical for its pharmacokinetic profile.

Recent advancements in computational chemistry have allowed for a deeper understanding of the molecular interactions of 6-Methyl-4-phenylquinazolin-2(1H)-one. Through molecular docking studies, scientists have identified potential binding sites on target proteins, providing insights into its mechanism of action. For instance, the compound has shown promising activity as an inhibitor of kinases, which are pivotal in regulating cellular signaling pathways. This makes it a valuable lead compound for developing novel therapeutic agents.

In addition to its pharmacological significance, 6-Methyl-4-phenylquinazolin-2(1H)-one has also been explored for its potential in materials science. Its aromatic structure and conjugated system make it a candidate for applications in organic electronics and optoelectronics. Researchers are investigating its ability to act as a semiconductor material or a component in light-emitting diodes (LEDs), highlighting its versatility across multiple disciplines.

The growing interest in 6-Methyl-4-phenylquinazolin-2(1H)-one is further evidenced by its inclusion in various high-throughput screening libraries used in drug discovery. Its structural flexibility allows for easy modification, enabling researchers to explore a wide range of analogs with enhanced bioactivity or improved pharmacokinetic properties. This adaptability positions the compound as a cornerstone for future innovations in medicinal chemistry.

In conclusion, 6-Methyl-4-phenylquinazolin-2(1H)-one (CAS No. 13961-64-3) stands out as a multifaceted molecule with immense potential across diverse fields. Its unique chemical structure, coupled with recent breakthroughs in synthetic and computational methodologies, continues to unlock new avenues for research and application. As ongoing studies shed more light on its properties and mechanisms, this compound is poised to make significant contributions to both medicine and materials science.

• 23441-75-0(4-Phenylquinazolin-2(1H)-one)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)